Pill better than chemotherapy for colon cancer patientsNovember 14th, 2007 - 1:52 am ICT by admin
“Standard chemotherapy can be incredibly disruptive to people’s lives. Patients visit hospital five days a week for the injections and then have three weeks off before returning to hospital for the next course - and the side effects can be unpleasant,” said lead researcher Prof Professor Chris Twelves.
Researchers say that Xeloda offers fewer side-effects and less time in hospital.
Prof Twelves’ trial on patients has shown that those given the drug were at least as likely to be alive and free of their disease as those on standard chemotherapy.
The study showed that about 71 percent of patients given Xeloda were still alive after five years, compared to 68 percent of patients treated with standard chemotherapy injections.
Prof Twelves’s study followed 1,987 patients who had undergone colon cancer surgery. It found that patients treated with Xeloda spent 85 percent less time with their doctor or at the hospital, and experienced fewer side effects.
The new results, showing patients’ five-year survival rates, confirm the effectiveness of the treatment.
“We now have long-term evidence now that clearly supports Xeloda’s superiority over the Mayo Clinic regimen. There is now no reason why we should ask colon cancer patients to endure the burdens associated with that older treatment,” said Prof Twelves. (ANI)
- Clinical trial offers hope for Hepatitis C patients - Mar 15, 2011
- New drug hope for lung cancer sufferers - Mar 29, 2011
- Targeted cancer drug more effective after first-line treatment - Feb 28, 2011
- Indian-origin scientist's finding offers hope for advanced cancer patients - Apr 06, 2011
- New procedure busts deadly brain tumour cells - Feb 06, 2012
- This drug can reduce breast cancer recurrence - Sep 27, 2011
- Gene test may bring safe chemotherapy - Mar 23, 2012
- India witnessing rise in pancreatic cancer, say doctors - Oct 06, 2011
- Cancer drug could combat ovarian tumours - Oct 12, 2010
- Targeted drug therapy shows promise against deadly form of lung cancer - Nov 02, 2010
- FDA approves personalized therapy for tough-to-treat colorectal cancer - Jul 26, 2012
- Osteoporosis drug may benefit patients with oral cancer - Dec 14, 2010
- Drug used to treat asthma 'prevents spread of breast cancer' - Nov 04, 2010
- New treatment strategy effective for certain lung cancers - Mar 11, 2011
- Herpes virus can treat head and neck cancer - Aug 02, 2010
Tags: alive and free, better chance, capecitabine, chemotherapy drug, chemotherapy injections, colon cancer patients, colon cancer surgery, five days a week, five year survival, mayo clinic, oral chemotherapy, professor chris, study showed that, survival rates, university of leeds, xeloda